Statement by Chip Davis, President and CEO, AAM, on HHS Secretary Nominee Tom Price WASHINGTON, DC (January 18, 2017) — “Congressman Price has a deep background and expertise in complicated health care issues and has been a leader in Read More →
AAM Statement Regarding President-Elect Trump’s Remarks on the Pharmaceutical Industry WASHINGTON DC (Jan. 11, 2017) – “We understand the President-Elect’s concerns about drug prices. Patients and drug purchasers like the federal government, health systems, employers Read More →